By employing a co-immunoprecipitation (“Co-IP”) assay, we show that Ninj2 immunoprecipitated with EGFR, PDGFRβ and FGFR in A172 cells and primary human glioma cells (“P1/P2”) (Figure 6A). This evidence concerns the gene EGFR and central nervous system cancer.